Similar to how CD45/SSC profiles are used to evaluate the blast count for MDS diagnoses, the analysis of other biomarkers in tandem with a CD45/SSC profile may be used to further enhance the accuracy of the diagnosis. The gene discussed is PTPRC; the disease is myelodysplastic syndrome.